Pavmed announced today that it executed a non-binding letter of intent to license endoscopic esophageal imaging technology from Duke University. Through a newly formed subsidiary, Pavmed licensed the technology designed to identify and facilitate treatment of advanced esophageal precancer (dysplasia) during upper endoscopy. It features a … [Read more...] about Pavmed licenses endoscopic esophageal imaging tech out of Duke
PAVmed
Pavmed, Novosound partner on catheter-delivered ultrasound tech
PAVmed (Nasdaq:PAVM) announced today that it entered into a license option and joint R&D agreement with Novosound. Glasgow, Scotland-based Novosound develops proprietary flexible thin-film ultrasound technology for medical imaging. The venture-backed company currently targets next-generation intravascular ultrasound (IVUS) imaging. PAVmed … [Read more...] about Pavmed, Novosound partner on catheter-delivered ultrasound tech
